Inflammation as a central mechanism in Alzheimer's disease

Cited by (1,008)

Items 701–800 of 1,008

1. Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer’s and Parkinson’s Diseases
   Hayate Javed, Nagoor Meeran Mohamed Fizur, Niraj Kumar Jha, Ghulam Md Ashraf, Shreesh Kumar Ojha · 2022 · Current Neuropharmacology
2. Shared Genes of PPARG and NOS2 in Alzheimer’s Disease and Ulcerative Colitis Drive Macrophages and Microglia Polarization: Evidence from Bioinformatics Analysis and Following Validation
   Longcong Dong, Yuan Shen, Hongying Li, Ruibin Zhang, Shuguang Yu, Qiaofeng Wu · 2023 · International Journal of Molecular Sciences
3. Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
   Emanuele Morena, Carmela Romano, Martina Marconi, Selene Diamant, Maria Chiara Buscarinu, Gianmarco Bellucci, Silvia Romano, Daniela Scarabino, Marco Salvetti, Giovanni Ristori · 2023 · International Journal of Molecular Sciences
4. Complexity of Sex Differences and Their Impact on Alzheimer’s Disease
   Marion Kadlecová, Kristine Freude, Henriette Haukedal · 2023 · Biomedicines
5. Purpose in life and markers of immunity and inflammation: Testing pathways of episodic memory
   A. Sutin, Y. Stephan, Martina Luchetti, A. Terracciano · 2023 · Journal of Psychosomatic Research
6. Temporal trends and disparities of population attributable fractions of modifiable risk factors for dementia in China: a time-series study of the China health and retirement longitudinal study (2011–2018)
   Shanquan Chen, Xi Chen, Xiaohui Hou, Hai Fang, Gordon G. Liu, Lijing L. Yan · 2024 · The Lancet Regional Health - Western Pacific
7. The role of exercise parameters on small extracellular vesicles and microRNAs cargo in preventing neurodegenerative diseases
   Francesco Fischetti, Luca Poli, Marina de Tommaso, Damiano Paolicelli, Gianpiero Greco, Stefania Cataldi · 2023 · Frontiers in Physiology
8. The relationship between the gut microbiota and oxidative stress in the cognitive function of schizophrenia: A pilot study in China
   Hehua Li, Yuanyuan Huang, Liqin Liang, Hanqiu Li, Shijia Li, Yangdong Feng, Shixuan Feng, Kai Wu, Fengchun Wu · 2024 · Schizophrenia Research
9. Polysaccharides extracted from common buckwheat (Fagopyrum esculentum) attenuate cognitive impairment via suppressing RAGE/p38/NF-κB signaling and dysbiosis in AlCl3-treated rats
   Yu-Chen Liu, Sheng-Yi Chen, Ying-Ying Chen, Hsin‐Yu Chang, I‐Chen Chiang, Gow‐Chin Yen · 2024 · International Journal of Biological Macromolecules
10. Unveiling the role of astrogliosis in Alzheimer’s disease Pathology: Insights into mechanisms and therapeutic approaches
    Mohit Paidlewar, Sneha Kumari, Rishika Dhapola, Prajjwal Sharma, Dibbanti HariKrishnaReddy · 2024 · International Immunopharmacology
11. Advanced biomarkers: Beyond amyloid and tau: Emerging non-traditional biomarkers for alzheimer`s diagnosis and progression
    Meher Rijwana Afrin, Pankaj Ghritakousik Upadhyaya, Abdul Hashim, Kunal Bhattacharya, Nongmaithem Randhoni Chanu, Dibyajyoti Das, Pukar Khanal, Satyendra Deka · 2025 · Ageing Research Reviews
12. Uncovering plaque-glia niches in human Alzheimer’s disease brains using spatial transcriptomics
    Denis R. Avey, Bernard Ng, Ricardo A. Vialle, Nicola A. Kearns, Kátia de Paiva Lopes, Artemis Iatrou, Sashini L De Tissera, Himanshu Vyas, Devin M. Saunders, Daniel J. Flood et al. · 2025 · Molecular Neurodegeneration Advances
13. The Emerging Role of COX-2, 15-LOX and PPARγ in Metabolic Diseases and Cancer: An Introduction to Novel Multi-target Directed Ligands (MTDLs)
    Rana A. Alaaeddine, Perihan A. Elzahhar, Ibrahim AlZaim, Wassim G. Abou-Kheir, Ahmed S.F. Belal, Ahmed Fawzy EL‐Yazbi · 2020 · Current Medicinal Chemistry
14. The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis
    Urati Anuradha, Anoop Kumar, Rakesh Kumar Singh · 2021 · Neurological Sciences
15. GPCR19 Regulates P2X7R-Mediated NLRP3 Inflammasomal Activation of Microglia by Amyloid β in a Mouse Model of Alzheimer’s Disease
    Jahirul Islam, Jung‐Ah Cho, Ju-yong Kim, Kyung Park, Young-Jae Koh, Chu Young Chung, Eun‐Jae Lee, Soo Jeong Nam, Kyoungyul Lee, Seoung-Heon Kim et al. · 2022 · Frontiers in Immunology
16. Andrographolide exerts a neuroprotective effect by regulating the LRP1-mediated PPARγ/NF-κB pathway
    Yue Ju, Lili Gu, Min Shan Hu, Miao Zheng, Xuebin Zhou, Qin Li, Xinyue Zhang · 2023 · European Journal of Pharmacology
17. The elusive role of herpesviruses in Alzheimer’s disease: current evidence and future directions
    Stacey L. Piotrowski, Allison Tucker, Steven Jacobson · 2023 · NeuroImmune Pharmacology and Therapeutics
18. Differential roles of regulatory T cells in Alzheimer's disease
    Abdollah Jafarzadeh, Abdolkarim Sheikhi, Zahra Jafarzadeh, Maryam Nemati · 2023 · Cellular Immunology
19. Comparison of the stability of glycoprotein acetyls and high sensitivity C ‐reactive protein as markers of chronic inflammation
    Daisy C P Crick, Golam Mohammed Khandaker, Sarah L. Halligan, David Paul Burgner, Toby Mansell, Abigail Fraser · 2023 · Immunology
20. Latest advances in mechanisms of epileptic activity in Alzheimer’s disease and dementia with Lewy Bodies
    Mariane Cristine Vicente, Kwaku Addo-Osafo, Keith A. Vossel · 2024 · Frontiers in Neurology
21. Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients
    Dawn C. Matthews, Jefferson W. Kinney, Aaron R. Ritter, Randolph D. Andrews, Erin N. Toledano Strom, Ana S. Lukic, Lauren N. Koenig, Carolyn Revta, Howard M. Fillit, Kate Zhong et al. · 2024 · Alzheimer s & Dementia Translational Research & Clinical Interventions
22. Cognitive Impairment in Patients with Ankylosing Spondylitis
    Bruno Kusznir Vitturi, Enrico Stefano Suriano, Ana Beatriz Pereira de Souza, Dawton Yukito Torigoe · 2020 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
23. Multitarget Profiling of a Strigolactone Analogue for Early Events of Alzheimer’s Disease: In Vitro Therapeutic Activities against Neuroinflammation
    Begum Kurt, Adem Ozleyen, Gizem Antika, Yakup Berkay Yılmaz, Tugba Boyunegmez Tumer · 2020 · ACS Chemical Neuroscience
24. Uncovering Plaque-Glia Niches in Human Alzheimer’s Disease Brains Using Spatial Transcriptomics
    Avey, Denis R., Ng, Bernard, Vialle, Ricardo A., Kearns, Nicola A., de Paiva Lopes, Katia, Iatrou, Artemis, De Tissera, Sashini, Vyas, Himanshu, Saunders, Devin M., Flood, Daniel J. et al. · 2024
25. Peripheral immune function and Alzheimer’s disease: a living systematic review and critical appraisal
    Chihua Li, Rebecca C. Stebbins, Grace A. Noppert, Constanza X. Carney, Chunyu Liu, Ashley R. M. Sapp, Elijah J. Watson, Allison E. Aiello · 2023 · Molecular Psychiatry
26. Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases
    Li Yang Tan, Grace Cunliffe, Michael Patrick Hogan, Xin Yi Yeo, Chansik Oh, Bohwan Jin, Junmo Kang, Junho Park, Min‐Soo Kwon, MinYoung Kim et al. · 2024 · Frontiers in Immunology
27. Inflammatory Manifestations Associated With Gut Dysbiosis in Alzheimer’s Disease
    Samat Kozhakhmetov, Aiym Kaiyrlykyzy, Zharkyn Jarmukhanov, E. B. Vinogradova, Gulnaz Zholdasbekova, Dinara Alzhanova, Jeannette Kunz, Almagul R. Kushugulova, Sholpan Askarova · 2024 · International Journal of Alzheimer s Disease
28. Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer’s disease continuum
    Junhao Wen, Zhijian Yang, Ilya M. Nasrallah, Yuhan Cui, Güray Erus, Dhivya Srinivasan, Ahmed Abdulkadir, Elizabeth Mamourian, Ioanna Skampardoni, Gyujoon Hwang et al. · 2024 · Translational Psychiatry
29. Hampered AMPK-ULK1 cascade in Alzheimer’s disease (AD) instigates mitochondria dysfunctions and AD-related alterations which are alleviated by metformin
    Arnaud Mary, Samantha Barale, Fanny Eysert, Audrey Valverde, Sandra Lacas‐Gervais, Charlotte Bauer, Sabiha Eddarkaoui, Luc Buée, Valérie Buée‐Scherrer, Frédéric Checler et al. · 2025 · Alzheimer s Research & Therapy
30. Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study
    Audrey Low, Li Su, James D. Stefaniak, Elijah Mak, Maria‐Eleni Dounavi, Graciela Muniz Terrera, Karen A. Ritchie, Craig William Ritchie, Hugh Stephen Markus, John Tiernan O'Brien · 2020 · Neurobiology of Aging
31. Inflammatory cytokine levels implicated in Alzheimer’s disease moderate the effects of sex on verbal memory performance
    Jessica Caldwell, Jefferson W. Kinney, Aaron R. Ritter, Arnold Salazar, Christina G. Wong, Dietmar Cordes, George M. Slavich · 2020 · Brain Behavior and Immunity
32. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents
    Kushagra Kashyap, Mohammad Imran Siddiqi · 2021 · Molecular Diversity
33. Cannabinoid receptor 2 selective agonists and Alzheimer's disease: An insight into the therapeutic potentials
    Magham Sai Varshini, Praveen Thaggikuppe Krishnamurthy, Neenu Shaji, Lalithkumar Mani, Shivaramakrishnan Balasubramanian · 2021 · Journal of Neuroscience Research
34. Preventing Alzheimer's disease within reach by 2025: Targeted‐risk‐AD‐prevention (TRAP) strategy
    Francesca Vitali, Gregory L. Branigan, Roberta Dı́az Brinton · 2021 · Alzheimer s & Dementia Translational Research & Clinical Interventions
35. Comparison of Oleocanthal-Low EVOO and Oleocanthal against Amyloid-β and Related Pathology in a Mouse Model of Alzheimer’s Disease
    Ihab M. Abdallah, Kamal M. Al-Shami, Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Claudia Guillaume, Amal Kaddoumi · 2023 · Molecules
36. Soluble and insoluble protein aggregates, endoplasmic reticulum stress, and vascular dysfunction in Alzheimer’s disease and cardiovascular diseases
    Emily W. Waigi, Robert Clinton Webb, Melissa A. Moss, Mark J. Uline, Cameron Grant McCarthy, Camilla Ferreira Wenceslau · 2023 · GeroScience
37. Is Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer’s disease?
    Oualid Sbai, Veronica Bazzani, Shreya Tapaswi, Joshua McHale, Carlo Vascotto, Lorena Perrone · 2023 · Frontiers in Molecular Neuroscience
38. SLGCN: Structure-enhanced line graph convolutional network for predicting drug–disease associations
    Bao-Min Liu, Ying-Lian Gao, Feng Li, Chun-Hou Zheng, Jin‐Xing Liu · 2023 · Knowledge-Based Systems
39. The shift in the fatty acid composition of the circulating lipidome in Alzheimer's disease
    Farida Dakterzada, Mariona Jové, José Luis Cantero, Natàlia Mota‐Martorell, Reinald Pamplona, Gerard Piñoll‐Ripoll · 2024 · Alzheimer s & Dementia
40. Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
    Mark E. Mapstone, Thomas J Gross, Fabio M. Macciardi, Amrita K. Cheema, Melissa E. Petersen, Elizabeth Head, Benjamin L. Handen, William Edward Klunk, Bradley T. Christian, Wayne P. Silverman et al. · 2020 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
41. Terpenoids of Ganoderma lucidum reverse cognitive impairment through attenuating neurodegeneration via suppression of PI3K/AKT/mTOR expression in vivo model
    Anqi Wang, Changhao Xiao, Jianxian Zheng, Chuansong Ye, Zhen Dai, Qinghai Wu, Jinguang Liu, Pádraig Strappe, Zhongkai Zhou · 2020 · Journal of Functional Foods
42. Mural Cells: Potential Therapeutic Targets to Bridge Cardiovascular Disease and Neurodegeneration
    Alexander Lin, Niridu Jude Peiris, Harkirat Dhaliwal, Maria Hakim, Weizhen Li, Subramaniam Ganesh, Yogambha Ramaswamy, Sanjay Patel, Ashish Misra · 2021 · Cells
43. Nonlinear and vibrational microscopy for label-free characterization of amyloid-β plaques in Alzheimer's disease model
    Renan Souza Cunha, Lucas Lafetá, Emerson Alberto Fonseca, Alexandre Simões Barbosa, Marco Aurélio Romano‐Silva, Rafael Pinto Vieira, Ado Jório, Leandro M. Malard · 2021 · The Analyst
44. Evaluation of anti-Alzheimer activity of Echinacea purpurea extracts in aluminum chloride-induced neurotoxicity in rat model
    Mohamed, Salma M., Shalaby, Mostafa A., Al‑Mokaddem, Asmaa K., El-Banna, Ahmed H., EL-Banna, Hossny A., Nabil, Ghazal · 2023 · Journal of Chemical Neuroanatomy
45. Control of the temporal development of Alzheimer’s disease pathology by the MR1/MAIT cell axis
    Wyatt-Johnson, Season K., Kersey, Holly N., Codocedo, Juan F., Newell, Kathy L., Landreth, Gary E., Lamb, Bruce T., Oblak, Adrian L., Brutkiewicz, Randy R. · 2023 · Journal of Neuroinflammation
46. Functional Role of Extracellular Vesicles in Skeletal Muscle Physiology and Sarcopenia: The Importance of Physical Exercise and Nutrition
    Mauro Lombardo, Gilda Aiello, Deborah Fratantonio, Sercan Karav, Sara Baldelli · 2024 · Nutrients
47. Association Between the Gut Microbiota and Alzheimer’s Disease: An Update on Signaling Pathways and Translational Therapeutics
    Rutweek Kulkarni, Sneha Kumari, Rishika Dhapola, Prajjwal Sharma, Sunil Kumar Singh, Bikash Medhi, Dibbanti HariKrishnaReddy · 2024 · Molecular Neurobiology
48. Inhibition of soluble epoxide hydrolase ameliorates cerebral blood flow autoregulation and cognition in alzheimer's disease and diabetes-related dementia rat models
    Chengyun Tang, Jane J. Border, Huawei Zhang, Andrew Gregory, Shan Bai, Xing Fang, Yedan Liu, Shaoxun Wang, Sung Hee Hwang, Wen‐Jun Gao et al. · 2025 · GeroScience
49. Gastrodin Ameliorates Tau Pathology and BBB Dysfunction in 3xTg‐AD Transgenic Mice by Regulating the ADRA1/NF‐κB/NLRP3 Pathway to Reduce Neuroinflammation
    Bo Li, Li Wang, Yan Chun Xiao, Yang Wang, Yuanshang Wang, Yaqian Peng, Anni Zhang, Zhi Tang, Xiaolan Qi · 2025 · Phytotherapy Research
50. Mitochondrial complex I deficiency induces Alzheimer's disease–like signatures that are reversible by targeted therapy
    Huanyao Gao, Kate N. Jensen, Jarred J. Nesbitt, Mark Ostroot, Gregory A. Cary, Jesse C. Wiley, Sergey Trushin, Jens O. Watzlawik, Wolfdieter Springer, Alexander S. Galkin et al. · 2025 · Alzheimer s & Dementia
51. Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms
    Aniket Kakkar, Harpreet Singh, Bhuvnesh Kumar Singh, Arvind Kumar, Arun Kumar Mishra, Hitesh Chopra · 2025 · Journal of Alzheimer s Disease
52. Endoplasmic reticulum stress and unfolded protein response in immune cell function
    Goshi Matsushima, Yuhki Yanase, Tadashi Nakagawa, Mitsuhiro Goda, Koichiro Ozawa, Toru Hosoi · 2025 · Frontiers in Immunology
53. Expression of Cyp2c/Cyp2j subfamily members and oxylipin levels during LPS‐induced inflammation and resolution in mice
    Joan P. Graves, J. Alyce Bradbury, Artiom Gruzdev, Hong Li, Caroline Duval, Fred Bjørn Lih, Matthew L. Edin, Darryl C. Zeldin · 2019 · The FASEB Journal
54. Cyclical amyloid beta-astrocyte activity induces oxidative stress in Alzheimer’s disease
    Shalini Elangovan, R. M. Damian Holsinger · 2020 · Biochimie
55. An Insight in Pathophysiological Mechanism of Alzheimer's Disease and its Management Using Plant Natural Products
    Zeba Firdaus, Tryambak Deo Singh · 2020 · Mini-Reviews in Medicinal Chemistry
56. Alterations of GABA B receptors in the APP/PS1 mouse model of Alzheimer's disease
    Arnold Salazar, Amanda M. Leisgang Osse, Andrew Adonay Ortiz, Andrew S. Murtishaw, Jefferson W. Kinney · 2020 · Neurobiology of Aging
57. An α-helix mimetic oligopyridylamide, ADH-31, modulates Aβ 42 monomer aggregation and destabilizes protofibril structures: insights from molecular dynamics simulations
    Anupamjeet Kaur, Deepti Goyal, Bhupesh Goyal · 2020 · Physical Chemistry Chemical Physics
58. Synergism and Subadditivity of Verbascoside-Lignans and -Iridoids Binary Mixtures Isolated from Castilleja tenuiflora Benth. on NF-κB/AP-1 Inhibition Activity
    Luis David Arango-De la Pava, Alejandro Zamilpa, José Luis Trejo‐Espino, Blanca Eda Domínguez-Mendoza, Enrique Jiménez‐Ferrer, Leonor Pérez‐Martínez, Gabriela Trejo‐Tapia · 2021 · Molecules
59. Nanotechnology as a therapeutic strategy to prevent neuropsychomotor alterations associated with hypercholesterolemia
    Matheus Scarpatto Rodrigues, Gabriela Cristina de Paula, Mariane Bernardo Duarte, Victória Linden de Rezende, Jonathann Corrêa Possato, Hémelin Resende Farias, Eduarda Behenck Medeiros, Paulo Emílio Feuser, Emilio Luiz STRECK, Ricardo Andrez Machado‐de‐Ávila et al. · 2021 · Colloids and Surfaces B Biointerfaces
60. Molecular subtyping of Alzheimer’s disease with consensus non-negative matrix factorization
    Chunlei Zheng, Rong Xu · 2021 · PLoS ONE
61. Diabetes and inflammatory diseases: An overview from the perspective of Ca2+/3'-5'-cyclic adenosine monophosphate signaling
    Leandro Bueno Bergantin · 2021 · World Journal of Diabetes
62. Dying by fire: noncanonical functions of autophagy proteins in neuroinflammation and neurodegeneration
    Alexis D. Rickman, Addison Hilyard, Bradlee L. Heckmann · 2021 · Neural Regeneration Research
63. Combination Therapy in Alzheimer’s Disease: Is It Time?
    Arash Salehipour, Motahareh Bagheri, Mohammadmahdi Sabahi, Mahsa Dolatshahi, Delphine Boche · 2022 · Journal of Alzheimer s Disease
64. Silk fibroin/cholinium gallate-based architectures as therapeutic tools
    Joana M. Gomes, Simone S. Silva, Emanuel M. Fernandes, Flávia C. M. Lobo, Manuel Martín‐Pastor, Pablo Taboada, Rui Luís Reis · 2022 · Acta Biomaterialia
65. Ginkgo Biloba Leaf Extract Improves an Innate Immune Response of Peripheral Blood Leukocytes of Alzheimer’s Disease Patients
    Marta Sochocka, Michał Ochnik, Maciej Sobczyński, Katarzyna Gębura, Aleksandra Zambrowicz, Piotr Naporowski, Jerzy Leszek · 2022 · Nutrients
66. Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer’s Disease Continuum
    Yi-He Chen, Rong-Rong Lin, Hui-Feng Huang, Yan‐Yan Xue, Qing‐Qing Tao · 2022 · Frontiers in Aging Neuroscience
67. Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease
    Farida Dakterzada, Mariona Jové, Raquel P Huerto, Anna Carnes, Joaquím Sol, Reinald Pamplona, Gerard Piñol‐Ripoll · 2023 · Aging and Disease
68. Early Life Obesity Increases Neuroinflammation, Amyloid Beta Deposition, and Cognitive Decline in a Mouse Model of Alzheimer’s Disease
    Simon W. So, Kendra M. Fleming, Joshua P. Nixon, Tammy A. Butterick · 2023 · Nutrients
69. Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
    Joke Temmerman, Sebastiaan Engelborghs, Maria Bjerke, Miguel D’haeseleer · 2023 · Frontiers in Immunology
70. Therapeutic considerations of bioactive compounds in Alzheimer's disease and Parkinson's disease: Dissecting the molecular pathways
    Banashree Chetia Phukan, Rubina Roy, Indira Gahatraj, Pallab Bhattacharya, Anupom Borah · 2023 · Phytotherapy Research
71. Chronic neuroinflammation during aging leads to cholinergic neurodegeneration in the mouse medial septum
    Rashmi Vasundhara Gamage, Ilaria Rossetti, Garry Niedermayer, Gerald W Münch, Yossi Buskila, Erika Gyengési · 2023 · Journal of Neuroinflammation
72. P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
    Qiang Huang, Jun Ying, Wen Yu, Yao Dong, Hao Xiong, Yiping Zhang, Jie Liu, Xifeng Wang, Fuzhou Hua · 2023 · Molecular Neurobiology
73. Risk of dementia in survivors of active tuberculosis in Korea: A nationwide cohort study
    Yohwan Yeo, Jung Eun Yoo, Kyungdo Han, Jin‐Hyung Jung, Hayoung Choi, Jongkyu Park, Dong Wook Shin, Hyun Jung Lee · 2023 · Journal of Infection and Public Health
74. Switching On/Off Amyloid Plaque Formation in Transgenic Animal Models of Alzheimer’s Disease
    Sergey A. Kozin, Olga I. Kechko, Alexei A. Adzhubei, Alexander А. Makarov, Vladimir A. Mitkevich · 2023 · International Journal of Molecular Sciences
75. iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype
    Sullivan, Michael A., Lane, Samuel D., McKenzie, André D. J., Ball, Sarah R., Sunde, Margaret, Neely, G. Gregory, Moreno, Cesar L., Maximova, Alexandra, Werry, Eryn L., Kassiou, Michael · 2024 · Journal of Neuroinflammation
76. Network pharmacology-based approach to elucidate the pharmacologic mechanisms of natural compounds from Dictyostelium discoideum for Alzheimer's disease treatment
    Nil Patil, Rupal Dhariwal, Arifullah Mohammed, Lee Seong Wei, Mukul Jain · 2024 · Heliyon
77. Trajectory of brain-derived amyloid beta in Alzheimer’s disease: where is it coming from and where is it going?
    Ni Liu, Anaer Haziyihan, Wei Guang Zhao, Yu Chen, Hongbo Chao · 2024 · Translational Neurodegeneration
78. The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction
    Keith W. VanDusen, Sarada Eleswarpu, Eugene W. Moretti, Michael J. Devinney, Donna Crabtree, Daniel T. Laskowitz, Marty G. Woldorff, Kenneth Roberts, John Whittle, Jeffrey N. Browndyke et al. · 2020 · Journal of Alzheimer s Disease
79. A microglia clonal inflammatory disorder in Alzheimer’s disease
    Vicario, Rocio, Fragkogianni, Stamatina, Weber, Leslie, Lazarov, Tomi, Hu, Yang, Hayashi, Samantha Y, Craddock, Barbara, Socci, Nicholas D, Alberdi, Araitz, Baako, Ann et al. · 2025 · eLife
80. Iron chelators: as therapeutic agents in diseases
    Zohreh Salimi, Mehdi Afsharinasab, Mehdi Rostami, Yaser Eshaghi Milasi, Seyedeh Fatemeh Musavi Ezmareh, Fariba Sakhaei, Maryam Mohammad-Sadeghipour, Sayyed Mehdi Rasooli Manesh, Zatollah Asemi · 2024 · Annals of Medicine and Surgery
81. Beneficial versus Detrimental Effects of Complement–Microglial Interactions in Alzheimer’s Disease
    Gunel Ayyubova, Nadeem Fazal · 2024 · Brain Sciences
82. Edaravone Dexborneol ameliorates the cognitive deficits of APP/PS1 mice by inhibiting TLR4/MAPK signaling pathway via upregulating TREM2
    Jinyang Wang, Longyuan Du, Tianyun Zhang, Yun Chu, Yue Wang, Yu Tian Wang, Xiaoming Ji, Yunxiao Kang, Rui Cui, Guoliang Zhang et al. · 2024 · Neuropharmacology
83. Extracellular vesicles in age-related diseases: disease pathogenesis, intervention, and biomarker
    Puan Haliza Lintang Putri, Samira Husen Alamudi, Xuan Dong, Ying Long Fu · 2025 · Stem Cell Research & Therapy
84. Nanoparticles for immunotherapy
    Clément Anfray, Francesco Mainini, Fernando Torres Andón · 2020 · Frontiers of nanoscience
85. Upregulation of Local Hepcidin Contributes to Iron Accumulation in Alzheimer’s Disease Brains
    Suman Chaudhary, Ajay Ashok, Dallas McDonald, Aaron S. Wise, Alexander E. Kritikos, Neil A. Rana, Clifford V. Harding, Neena Singh · 2021 · Journal of Alzheimer s Disease
86. Serum and cerebrospinal fluid Neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer's disease dementia
    Petrus J.W. Naudé, Inez H.G.B. Ramakers, Wiesje M. van der Flier, Lize Corrine Jiskoot, Fransje E. Reesink, Jurgen A.H.R. Claassen, Huiberdina L. Koek, Ulrich L.M. Eisel, Peter Paul De Deyn · 2021 · Neurobiology of Aging
87. Long-Term Treatment of Cuban Policosanol Attenuates Abnormal Oxidative Stress and Inflammatory Response via Amyloid Plaques Reduction in 5xFAD Mice
    Jinho Kim, Dong-Kyun Lim, Yoo‐Hun Suh, Keun‐A Chang · 2021 · Antioxidants
88. Omarigliptin/galangin combination mitigates lipopolysaccharide-induced neuroinflammation in rats: Involvement of glucagon-like peptide-1, toll-like receptor-4, apoptosis and Akt/GSK-3β signaling
    Ahmed M. Kabel, Hany H. Arab, Aliaa Atef, Remon S. Estfanous · 2022 · Life Sciences
89. Mesenchymal Stem Cells Improve Cognitive Impairment and Reduce Aβ Deposition via Promoting AQP4 Polarity and Relieving Neuroinflammation in Rats With Chronic Hypertension-Induced Cerebral Small-Vessel Disease
    Xiao lu Liu, Fubing Ouyang, Liu ting Hu, Pei Sun, Jing Yang, Yuan jing Sun, Mengshi Liao, Linfang Lan, Zhong Pei, Yu Fan · 2022 · Frontiers in Aging Neuroscience
90. Synthesis and biological evaluation of thieno[3,2- c ]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer’s disease
    Ning Yan, Xiaolong Shi, Long-Qian Tang, Defeng Wang, Xun Li, Chao Liu, Zhaopeng Liu · 2022 · Journal of Enzyme Inhibition and Medicinal Chemistry
91. Early-life stress and dietary fatty acids impact the brain lipid/oxylipin profile into adulthood, basally and in response to LPS
    Kitty Reemst, Jelle Y. Broos, Maralinde R. Abbink, Chiara Cimetti, Martin A. Giera, Gijs Kooij, Anikó Kőrösi · 2022 · Frontiers in Immunology
92. The Impairment of Blood-Brain Barrier in Alzheimer’s Disease: Challenges and Opportunities with Stem Cells
    Adolfo López-Ornelas, Adriana Jiménez, Gilberto Pérez‐Sánchez, Citlali Ekaterina Rodríguez-Pérez, Alejandro Corzo‐Cruz, Iván Velasco, Enrique Estudillo · 2022 · International Journal of Molecular Sciences
93. Targeting the liver in dementia and cognitive impairment: Dietary macronutrients and diabetic therapeutics
    Nicholas J. Hunt, Devin Wahl, Lara J. Westwood, Glen P. Lockwood, David George Le Couteur, Victoria Carroll Cogger · 2022 · Advanced Drug Delivery Reviews
94. High resolution 16S rRNA gene Next Generation Sequencing study of brain areas associated with Alzheimer’s and Parkinson’s disease
    David C. Emery, Maria Davies, Tanya L. Cerajewska, Jelena Taylor, Mae Hazell, Alex R. Paterson, Shelley Jane Allen, Nicola Xania West · 2022 · Frontiers in Aging Neuroscience
95. α7 nicotinic acetylcholine receptor in memory processing
    Verónica Estela Pastor, Jorge Horacio Medina · 2023 · European Journal of Neuroscience
96. Serum levels of IL-6 are associated with cognitive impairment in the salus in apulia population-based study
    Chiara Griseta, Petronilla Battista, Fabio Castellana, Isabella Colonna, Sabrina Sciarra, Roberta Zupo, Ilaria Bortone, Luisa Lampignano, Sarah Tirelli, Giuseppe Berardino et al. · 2023 · Heliyon
97. Hotspots and trends of microglia in Alzheimer's disease: a bibliometric analysis during 2000–2022
    Lijie Zhang, Qiuru Yao, Jinjing Hu, Baizhi Qiu, Yupeng Xiao, Qi Zhang, Yuting Zeng, Shuqi Zheng, Youao Zhang, Yantong Wan et al. · 2024 · European journal of medical research
98. Neuroprotective potential of Erigeron bonariensis ethanolic extract against ovariectomized/D-galactose-induced memory impairments in female rats in relation to its metabolite fingerprint as revealed using UPLC/MS
    Weam W. Ibrahim, Rabab Hamed Sayed, Mohamed Fayed Abdelhameed, Enayat Abdel Aziz Omara, Mahmoud I. Nassar, Noha F. Abdelkader, Mohamed Ali Farag, Abdelsamed I. Elshamy, Sherif Mahmoud Afifi · 2024 · Inflammopharmacology
99. Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia
    Charles L. Greenblatt, Richard Lathe · 2024 · Journal of Alzheimer s Disease
100. Research Progress on the Pathogenesis, Diagnosis, and Drug Therapy of Alzheimer’s Disease
     Yixuan Yang, Lina Qiu · 2024 · Brain Sciences